Stephanie D. Turner

Substrate-Dependent Modulation of CYP3A4 Catalytic Activity: Analysis of 27 Test Compounds with Four Fluorometric Substrates

David M. Stresser, Andrew P. Blanchard, Stephanie D. Turner et al. · Drug Metabolism and Disposition · 2000 · 273 citations

Cytochrome P450 Fluorometric Substrates: Identification of Isoform-Selective Probes for Rat CYP2D2 and Human CYP3A4.

David M. Stresser, Stephanie D. Turner, Andrew P. Blanchard et al. · Drug Metabolism and Disposition · 2002 · 161 citations

A High-Throughput Screen to Identify Inhibitors of Aromatase (CYP19)

David M. Stresser, Stephanie D. Turner, Joanne McNamara et al. · Analytical Biochemistry · 2000 · 136 citations

Biochemistry, Medicine, High-throughput Screen +6

HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE

David M. Stresser, Marc I. Broudy, Thuy Ho et al. · Drug Metabolism and Disposition · 2004 · 128 citations

Fluorometric High‐Throughput Screening for Inhibitors of Cytochrome P450

Vaughn P. Miller, David M. Stresser, A. P. Blanchard et al. · Annals of the New York Academy of Sciences · 2000 · 91 citations

Drug Target, Pharmacotherapy, Physiologically-based Pharmacokinetic Modeling +17